Press release
Tuberculosis Market Size is anticipated to Increase during the Study Period, 2019-2032
The Tuberculosis market report provides current treatment practices, emerging drugs, Tuberculosis market share of the individual therapies, current and forecasted Tuberculosis market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Tuberculosis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Tuberculosis market.
Key takeaways from the Tuberculosis Market Report
• As per CDC (2020), males accounted for 60.6% of TB cases in the United States in 2020.
• According to the World Health Organization (WHO), in 2021, an estimated 10.6 million people fell ill with TB worldwide. Six million men, 3.4 million women and 1.2 million children. TB is present in all countries and age groups. Globally, TB incidence is falling at about 2% per year and between 2015 and 2020 the cumulative reduction was 11%.
• The leading Tuberculosis Market Companies include Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd, Proswell Medical Corporation, Otsuka Pharmaceutical Development & Commercialization Inc., Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Sanofi, Novartis Pharmaceuticals, and others.
• Promising Tuberculosis Pipeline Therapies include Control, Indacaterol, Levofloxacin, BCG SII, VPM1002, Delamanid + OBR, FS-1, Vaccae, Arm A Double-blind Phase: TMC207, and others.
For more insights into the Tuberculosis Market Landscape, visit Tuberculosis Market Therapeutics Landscape @ https://www.delveinsight.com/sample-request/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Tuberculosis Overview
Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but TB bacteria can attack any part of the body such as the kidney, spine, and brain. Not everyone infected with TB bacteria becomes sick. As a result, two TB-related conditions exist: latent TB infection (LTBI) and TB disease.
Recent Developmental Activities in the Tuberculosis Treatment Landscape
• BNT164 (BioNTech) is being investigated in a Phase Ia, randomized, placebo-controlled, observer-blind, dose-finding evaluation trial to describe the safety, reactogenicity, and immunogenicity of two investigational vaccines against TB in IGRA-negative, BCG naïve Subjects. The estimated primary completion date of the study is June 2025.
• GlaxoSmithKline is developing GSK2556286 for the treatment of TB. The drug is currently being evaluated in a Phase I randomized, double blind (sponsor unblinded), placebo-controlled, first time in human study to evaluate the safety, tolerability and pharmacokinetics of single and repeat oral doses and the food effect of GSK2556286 in healthy adult participants. The study is estimated to complete in December 2023.
Tuberculosis Epidemiology Segmentation in the 7MM
• Total Tuberculosis Incident Cases
• Tuberculosis Site-specific Cases
• Tuberculosis Age-specific Cases
• Tuberculosis Gender-specific Cases
• Tuberculosis Treated Cases
Download the report to understand which factors are driving Tuberculosis epidemiology trends, visit here for Tuberculosis Epidemiological Insights @ https://www.delveinsight.com/sample-request/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Tuberculosis Market Insights
People living with HIV are 16 (Uncertainty interval: 14-18) times more likely to fall ill with TB disease than people without HIV. HIV and TB form a lethal combination, each speeding the other's progress. In 2021, about 187,000 people died of HIV-associated TB. The percentage of notified TB patients who had a documented HIV test result in 2021 was only 76%, up from 73% in 2020.
Tuberculosis Treatment Market
Tuberculosis treatment usually involves taking antibiotics for several months. While TB is a serious condition that can be fatal if left untreated, deaths are rare if treatment is completed. Most people do not need to be admitted to hospital during treatment. TB is a treatable and curable disease. Drug-susceptible TB disease is treated with a standard 4-month or 6-month course of 4 antimicrobial drugs that are provided with support to the patient by a health worker or trained treatment supporter. Without such support, treatment adherence is more difficult.
Tuberculosis Market Dynamics
The dynamics of the TB market is anticipated to change in the coming years owing to the improvement in the rise in number of healthcare spending across the world. Players, such as GlaxoSmithKline, BioNTech, and others are involved in developing drugs for TB and associated conditions.
Browse More Related Reports of the Tuberculosis Market Research Reports, click here for Tuberculosis Market Forecast @ https://www.delveinsight.com/sample-request/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Tuberculosis Market Report
• Coverage- 7MM
• Tuberculosis Companies- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd, Proswell Medical Corporation, Otsuka Pharmaceutical Development & Commercialization Inc., Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Sanofi, Novartis Pharmaceuticals, and others.
• Tuberculosis Pipeline Therapies- Control, Indacaterol, Levofloxacin, BCG SII, VPM1002, Delamanid + OBR, FS-1, Vaccae, Arm A Double-blind Phase: TMC207, and others.
• Tuberculosis Market Dynamics: Tuberculosis Market Drivers and Barriers
• Tuberculosis Market Access and Reimbursement, Unmet Needs, Future Perspectives
Read the Full Research Report of the Tuberculosis Market Forecast Report, click here for Tuberculosis Market Drivers and Barriers @ https://www.delveinsight.com/sample-request/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Executive Summary of Tuberculosis
3. Competitive Intelligence Analysis for Tuberculosis
4. Tuberculosis: Market Overview at a Glance
5. Tuberculosis: Disease Background and Overview
6. Patient Journey
7. Tuberculosis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Tuberculosis Unmet Needs
10. Key Endpoints of Tuberculosis Treatment
11. Tuberculosis Marketed Products
12. Tuberculosis Emerging Therapies
13. Tuberculosis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Tuberculosis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Consult with our Business Expert regarding "Tuberculosis Market Landscape" @ https://www.delveinsight.com/sample-request/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Trending Market Reports in 2023
Healthcare Partner Identification Services @ https://www.delveinsight.com/consulting/partner-identification-services
Medical Marijuana Market @ https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Oncolytic Virus Cancer Therapy Pipeline @ https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-pipeline-insight-2021
Overactive Bladder Syndrome Market @ https://www.delveinsight.com/report-store/overactive-bladder-market
Pediatric Growth Hormone Deficiency PGHD Market @ https://www.delveinsight.com/report-store/pediatric-growth-hormone-deficiency-market
Percutaneous Arterial Closure Device Market @ https://www.delveinsight.com/report-store/percutaneous-arterial-closure-device-market
Ranibizumab Biosimilars Insight @ https://www.delveinsight.com/report-store/ranibizumab-biosimilars-insight
Schistosomiasis Market @ https://www.delveinsight.com/report-store/schistosomiasis-market
Stem Cell Market @ https://www.delveinsight.com/report-store/stem-cell-market
Superficial Punctate Keratitis Market @ https://www.delveinsight.com/report-store/superficial-punctate-keratitis-market
Technical Due Diligence @ https://www.delveinsight.com/consulting/due-diligence-services
Transient Ischemic Attack Market @ https://www.delveinsight.com/report-store/transient-ischemic-attack-market
Wilms Tumor Market @ https://www.delveinsight.com/report-store/wilms-tumor-market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Yash Bhardwaj
info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tuberculosis Market Size is anticipated to Increase during the Study Period, 2019-2032 here
News-ID: 2987588 • Views: …
More Releases from DelveInsight Business Research
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
Global Cerebrospinal Fluid Management Market Poised to Reach USD 1,001.28 Millio …
The global Cerebrospinal Fluid (CSF) Management Market is projected to increase from USD 671.17 million in 2024 to USD 1,001.28 million by 2032, reflecting strong and sustained growth. The market is expected to grow at a CAGR of 5.18% during the forecast period (2025-2032), fueled by the rising prevalence of neurological disorders, increasing trauma-related cases, and significant advancements in device innovation and regulatory approvals.
Download our in-depth CSF Management Market Report…
More Releases for Tuberculosis
Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the…
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of…
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032.
Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over…
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does.
March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per…
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Ocular tuberculosis is a type…
